Syntaxin 19 activators are chemicals that can influence the broader cellular processes in which this protein plays a pivotal role. STX19 is integral to vesicle trafficking and membrane fusion events within cells, and any chemical that modulates these underlying processes can indirectly activate or affect the function of STX19.
At the forefront of these activators are agents that mediate intracellular calcium levels. Calcium ions are quintessential in vesicle fusion events, and chemicals such as thapsigargin and ionomycin, which elevate cytosolic calcium levels, are key players in this category. BAPTA-AM, a calcium chelator, adds another layer of modulation by altering calcium dynamics. Vesicle trafficking is also heavily influenced by the cytoskeletal network. Agents like nocodazole, which disrupt microtubule function, and taxol, which stabilizes microtubules, exemplify the impact of microtubule dynamics on vesicle transport. Similarly, the actin cytoskeleton's modulators, latrunculin A, which disrupts actin filaments, and jasplakinolide, which stabilizes them, can impact vesicle movement and, by extension, STX19's function. Monensin, which alters intracellular ion levels, also plays a role in this intricate process. Lastly, methyl-β-cyclodextrin's ability to extract cholesterol from membranes provides a unique approach, highlighting the importance of lipid environments in vesicle fusion processes where STX19 operates.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calcium | 7440-70-2 | sc-252536 | 5 g | $209.00 | ||
Calcium ions play a role in vesicle fusion events. Modulating calcium levels can impact Syntaxin 19's vesicle trafficking function. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Elevates cytosolic calcium levels, influencing vesicle fusion processes where STX19 might be involved. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, potentially affecting STX19's vesicle trafficking function. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Chelates calcium and, by affecting calcium dynamics, can influence vesicle fusion processes related to STX19. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Disrupts microtubule function. Given microtubules' role in vesicle trafficking, this can affect STX19 function. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules and can influence vesicle trafficking pathways involving STX19. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Alters intracellular ion levels, potentially affecting vesicle trafficking processes related to STX19. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Disrupts actin filaments, which play a role in vesicle movement and can thus influence STX19's function. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments, potentially affecting vesicle trafficking processes related to STX19. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Extracts cholesterol from membranes, which can affect vesicle fusion and trafficking processes involving STX19. | ||||||